• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

American Society of Hematology (ASH)

blood test money
Research

ASH launches $12M fund for scientists who lose federal grants

The investment is part of the society's new initiative to garner support for hematology research and support scientists in the field.
Darren Incorvaia Jun 10, 2025 4:32pm
blood test vial

ASH surveys identify barriers to improving diversity in research

Dec 16, 2024 5:10pm
throw away trash garbage bin

45 days later, BioCryst abandons another drug, citing competition

Dec 15, 2022 10:29am
target goal darts

ASH: Regeneron lymphoma med scores but safety muffles excitement

Dec 12, 2022 5:30pm
DNA

ASH: Senti Bio's CAR-NK therapy shows promise in leukemia

Dec 9, 2021 9:05am
Allogene Therapeutics Co-Founders Arie Belldegrun and David Chang

Allogene CAR-T posts 60% response rate in competitive BCMA field

Dec 7, 2020 8:03am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings